Quarterly Consolidated Statement Of Cash Flows

Daito Pharmaceutical Co., Ltd. - Filing #7730500

Concept As at
2017-11-30
2017-06-01 to
2017-11-30
As at
2017-05-31
2016-06-01 to
2016-11-30
As at
2016-11-30
As at
2016-05-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,511,413,000 JPY
2,391,674,000 JPY
Interest and dividends received
40,716,000 JPY
41,135,000 JPY
Interest paid
-13,972,000 JPY
-14,796,000 JPY
Income taxes paid
-963,606,000 JPY
-304,375,000 JPY
Net cash provided by (used in) operating activities
1,613,239,000 JPY
2,143,030,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,984,829,000 JPY
-1,340,611,000 JPY
Other, net
-15,552,000 JPY
12,649,000 JPY
Net cash provided by (used in) investing activities
-2,004,371,000 JPY
-1,330,043,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
1,100,000,000 JPY
1,000,000,000 JPY
Repayments of long-term borrowings
-1,134,797,000 JPY
-1,168,169,000 JPY
Purchase of treasury shares
-493,000 JPY
-139,000 JPY
Dividends paid
-223,327,000 JPY
-187,751,000 JPY
Net cash provided by (used in) financing activities
472,198,000 JPY
-519,957,000 JPY
Effect of exchange rate change on cash and cash equivalents
12,917,000 JPY
-21,627,000 JPY
Net increase (decrease) in cash and cash equivalents
93,983,000 JPY
271,401,000 JPY
Cash and cash equivalents
1,711,320,000 JPY
1,617,337,000 JPY
1,622,536,000 JPY
1,351,135,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.